Nanoparticle Applications in Antimicrobial Therapy

Rising antimicrobial resistance and biofilm-associated infections have prompted intensive research into nanoscale solutions that either carry traditional drugs or exert intrinsic microbicidal effects. Engineered nanoparticles can disrupt microbial membranes, generate reactive oxygen species and interfere with critical bacterial pathways. They also offer tailored delivery, releasing payloads in response to local pH or enzymatic triggers and concentrating antibiotics at sites of infection. Metal-based particles (silver, gold, zinc oxide), lipid-based vesicles and polymeric carriers each present unique advantages, from broad-spectrum activity to enhanced biocompatibility. By penetrating biofilms and entering host cells, nanoparticles overcome barriers that impede conventional therapies. Synergistic combinations of nanoparticles and antibiotics can restore efficacy against multidrug-resistant pathogens, while active targeting strategies—such as ligand modification or magnetic guidance—focus antimicrobial action and reduce off-target toxicity. As design parameters become better understood, nanoparticle platforms promise to transform the clinical management of persistent and resistant infections on a global scale.

Research from Nature Portfolio

New approaches have demonstrated that antibiotic-loaded lipid-coated gold nanoparticles can efficiently eradicate established biofilms and kill intracellular pathogens within macrophages. These constructs combine a biocompatible phospholipid shell with a core metal nanoparticle, enabling sustained release of cargo and promoting uptake by phagocytic cells. In vitro studies show improved elimination of both Gram-positive and Gram-negative biofilms compared with free antibiotics and negligible cytotoxicity to host cells. This platform exemplifies how nanoscale vehicles can address chronic infections by merging intrinsic nanoparticle properties with conventional antimicrobials.

Nanoparticle Applications in Antimicrobial Therapy publication trend

The graph below shows the total number of articles in nanoparticle applications in antimicrobial therapy across all publications each year (not limited to Nature Index journals).

Technical terms

Biofilm: A structured community of microorganisms encased in a self-produced polymeric matrix that adheres to surfaces and exhibits high resistance to antimicrobials.

Nanocarrier: A nanoscale vehicle designed to transport therapeutic agents, protecting them from degradation and delivering them to specific sites.

Passive targeting: The accumulation of nanoparticles at infected tissues driven by physiological factors such as enhanced permeability and retention.

Active targeting: The use of specific ligands, magnetic fields or stimuli-responsive moieties to direct nanoparticles to pathogens or infection niches.

Antimicrobial resistance: The ability of microorganisms to survive exposure to drugs designed to inhibit or kill them, often due to genetic mutations or biofilm formation.

References

1. Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes. Molecules (2016).
2. Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms. Frontiers in Pharmacology (2019).
3. Potent Antibacterial Nanoparticles against Biofilm and Intracellular Bacteria. Scientific Reports (2016).
4. Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances. Frontiers in Chemistry (2020).